Objectives: The increasing age of the population has raised the importance of determining the minimally required surgical treatment for elderly lung cancer patients. Despite a number of previous studies, the therapeutic impact of a radical mediastinal lymphadenectomy (RLA) associated with a pulmonary resection for lung cancer remains controversial. Herein, we investigated the impact of lymph node dissection on the overall survival for elderly lung cancer patients and assessed whether the non-performance of an RLA could be justified in the surgical treatment for these elderly patients. Methods: We analysed the data for 160 patients aged 70 years and older (113 males, 47 females) who underwent curative-intent surgery for non-small-cell lung cancer. They were divided into two groups, according to the method used for the intra-operative mediastinal lymph node dissection, the radical systematic lymphadenectomy (RLA, n = 76) and the non-radical lymphadenectomy (NLA, n = 94) groups. A Cox proportional hazards model and the Kaplan-Meier method were used for the survival analyses. Propensity-based analyses were also used to reduce the effect of non-randomisation and possible bias in indication of treatment between the two groups. Results: RLAs had no protective effect on mortality; the hazard ratio for the RLA group in comparison to the NLA group was 0.97 (95% confidence interval (CI): 0.32-2.89) in the multivariate analysis and 1.43 (95% CI: 0.42-4.91) in the propensity-based stratifying analysis. The 3-year survival probability was 81.3% (95% CI: 67.1-89.8) for the NLA group, which was marginally better than that of the RLA group (77.5% (95% CI: 63.3-86.8)). There was no significant difference in the overall survival between the two groups ( p = 0.26). The 3-year survival probability of the NLA group at each quartile of the propensity score also tended to be better than that of the RLA group, which did not show any significant difference. Conclusions: There was no survival benefit shown for RLA associated with pulmonary resections in the present cohort, even in the propensity-based analyses. Although some reports recommend a systematic mediastinal lymphadenectomy for proper staging and better survival, a pulmonary resection with nonperformance of radical lymphadenectomy could be an acceptable surgical treatment for the increasing number of elderly lung cancer patients. #
Introduction
Lung cancer is now the leading cause of death worldwide as well as a major disease of the elderly. The number of the older-aged patients with lung cancer has increased during the last decade all over the world, as well as in Japan. The data of the cancer registry of Japan in 2003 showed that as many as 63.2% of lung cancers were diagnosed in patients older than 70 years of age and 24.6% in older than 80 years of age [1] .
Conversely, the life expectancy for 70-and 80-year-old males in Japan in 2005 was 14.4 and 8.2 years, respectively, and for the same-aged females it was 18.9 and 11.1 years, respectively. Therefore, these data suggest that the lifelimiting factor in the elderly with lung cancer is not their age, but rather their disease.
Although age has been reported to be an independent predictor of post-surgical survival, several recent surgical series confirmed that acceptable long-term survival could be achieved in elderly lung cancer patients who underwent a curative pulmonary resection [2] [3] [4] [5] [6] . Brock et al. reported that the resectability rate of the octogenarians with lung cancer was 17%, advocating that a pulmonary resection could be done even among this population with proper selection [6] . However, the morbidity associated with a pulmonary resection in the elderly has been reported to be higher, in comparison to the younger population [2] . This information may indicate the importance of finding the best treatment modality in these elderly with lung cancer, since thoracic surgeons will face an increasing proportion of older-aged patients in the near future.
The standard surgical procedure for non-small-cell lung cancer (NSCLC), for a long time in the world, has been done as a lobectomy with a radical mediastinal lymphadenectomy (RLA) [7, 8] . However, the impact of RLA on overall survival (OS) after surgery remains controversial [9, 10] . Recent reports indicate that a strategy without an RLA (non-radical lymphadenectomy, NLA) may be an alternative to standard procedure for clinical stage I lung cancer [11] . In addition, an anatomical pulmonary resection without an RLA could be an acceptable procedure because elderly lung cancer patients have been reported to be more susceptible to surgical stress [12] . In practice, we mainly perform NLA for patients with no apparent lymph node metastases or with poor pulmonary reserve, or higher-aged patients, although there are no predefined criteria for the type of lymphadenectomy. The purpose of this study is to estimate how RLA impacts the longterm survival and to assess whether the non-performance of RLA could be justified in the surgical treatment for elderly lung cancer patients. This series also used a propensity-based analysis to reduce the unfavourable effect of non-randomisation and a possible bias in the indication of treatment between the different procedure groups.
Patients and methods

Patients
This study analysed the data for patients aged 70 years and older, who underwent curative-intent surgery for NSCLC between 2004 and 2008 at Nagoya University Hospital. Data were extracted from the electronic patient medical records, and databases for the division of thoracic surgery. Tumour staging consisted of computed tomography (CT) of the chest, positron emission tomography and either contrast-enhanced CT or magnetic resonance imaging of the brain. All patients had pulmonary function tests performed, and those with a % forced expiratory volume in 1 s (%FEV1.0) worse than 70% were considered to be complicated with chronic obstructive pulmonary disease (COPD). Preoperative data were collected including age, sex, clinical stage, arterial blood gas and the serum carcinoembryonic antigen (CEA) level. Other preoperative information concerning diabetes mellitus, smoking status and neo-adjuvant chemotherapy was also gathered. The smoking status was stratified according to the pack-years (PY) as never smoker, moderate smoker (0 < PY < 40) and heavy smoker (40 PY). Follow-up information was obtained for all survivors, and the survival status was determined from the date of last follow-up in a hospital outpatient clinic or a telephone interview.
Surgical technique
The resection of the lung cancer was the same in both groups, with a conventional lobectomy, segmentectomy, bilobectomy and pneumonectomy, in some cases combined with bronchoplasty. All patients underwent a standard posterolateral thoracotomy or anteroaxillary thoracotomy, entering in the fourth or fifth intercostal space. The lymph node stations were defined according to the lymph node map for lung cancer established by Naruke et al. [13] .
All patients were retrospectively divided into two groups according to the procedure used for the lymph node resection. The RLA group underwent a systematic mediastinal lymphadenectomy based on the radical en bloc mediastinal lymph node resection as described by Naruke and by Martini, which was slightly modified (level 2 and 3 lymph nodes were not resected in left-side cancers) [8, 13] . The NLA group underwent simple pulmonary resection with only a hilar lymph node resection or selective mediastinal lymph node dissection, thus undergoing neither a radical systematic mediastinal lymphadenectomy nor a systematic lymph node sampling.
Propensity-score calculation
As this study was not randomised, the patients who underwent a pulmonary resection with an NLA could not have the same risk of postoperative survival as those with an RLA. A propensity score (PS) analysis was used to reduce the unfavourable effect of non-randomisation and possible bias in the indications of treatment between the two procedure groups. The theoretical basis of this has been published elsewhere [14] . Briefly, PS is defined as the conditional probability of assignment to a particular treatment given a vector of preoperatively observed covariates. PSs are used to create matched pairs or matched sets that are balanced with respect to many observed covariates. The resulting matched sets are heterogeneous within the covariates, but the covariates aim to have uniform distributions between the two groups, which make the groups comparable as a whole. Accordingly, the results obtained by a retrospective study using a PS are assumed almost similar to those obtained by Table 1 Covariates that are expected to be a potential contributing factor for determining the dissection types of mediastinal lymph nodes. prospective randomised controlled trials. The propensitybased analysis in this series was carried out to estimate the probability that a patient might undergo an RLA, and patients with the same PS have the same probability of receiving an RLA or NLA.
Practically at first, a logistic regression analysis of several preoperative variables was performed to generate a single PS for each patient, using the 'pscore' command in the STATA ver.10 software package (STATA, College Station, TX, USA) [15] . All of the possible covariates that could be traced and that were expected to be a potential contributing factor for determining whether or not a patient would receive an RLA were included. Fifteen such factors were included for the calculation of the PS, which are summarised in Table 1 .
After the calculation of their PS, subjects were divided into four groups according to the quartile. The propensitybased stratification was used to produce estimates of the effect of each procedure based on better-balanced cohort. The covariates in both groups tended to be similarly distributed within the PS strata.
Statistic analyses for baseline characteristics and survival
Differences between the two groups were examined by unpaired Student's t-test for continuous valuables and the x 2 or Fisher's exact test for categorical valuables. OS was defined as the interval between the date of operation and final date of observation or date of death. Survival probability at specific periods after operation was obtained using the Kaplan-Meier product limit method, and comparison of the RLA and NLA groups was conducted using the log- rank test. A Cox proportional hazard regression model was also used to regress survival after the lung resection with stratification by the PS quartile, which aimed to remove the residual confounding after the PS stratification. The Cox proportional hazard model was computed with forward stepwise covariate selection (threshold p values for removal and inclusion were 0.20 and 0.10, respectively). Table 1 shows the 15 covariates that are expected to be a potential contributing factor for determining the dissection types of mediastinal lymph nodes, which are also examined in the stepwise Cox proportional hazard model. All the statistical analyses were conducted with the STATA ver.10 statistical software package [15] . The values were considered to be statistically significant at p < 0.05.
Results
Demographics
This study reviewed 160 patients aged 70 years and older, 113 males and 47 females, with a median age of 74 years (range: 70-85 years). Based on age, the patients were grouped into the following three categories: 70-74 years (n = 92, 57.5%), 75-79 years (n = 49, 30.6%) and 80 years or over (n = 19, 11.9%). Table 2 shows the patient profiles based on detailed medical records. All patients were divided into two groups according to the dissection types of the mediastinal lymph nodes, 89 were treated with NLA and 71 with RLA. The histological tumour analysis detected 94 adenocarcinomas, 54 squamous cell carcinomas, five largecell carcinomas and seven other histological cancers. As expected, there was an indication of a possible selection bias, with patients who did not undergo an RLA being significantly older, more likely to be better clinical stages. Heavy smokers tended to be more common in the RLA group. Table 3 shows the distribution of the patient characteristics for each procedure group according to the PS quartile. The background characteristics in each PS quartile were equally distributed between the two groups, although the frequency of heavy smoker was significantly higher in the RLA group in the highest quartile group.
Survival
There was no surgical death in both groups. The overall 3-year survival probability was 79.4% (95% confidence interval (CI): 69.9-86.1). Fig. 1 shows the unadjusted Kaplan-Meier survival curves for the patients with each procedure group. The crude 3-year survival probability was 81.3% (95% CI: 67.1-89.8) for the NLA group, which was marginally better than that of the RLA group (77.5% (95% CI: 63.3-86.8)). There was no significant difference in OS between the two groups ( p = 0.26). Even when survival probability was analysed separately within each PS quartile, there was no significant difference between the two groups. As shown in Table 4 , the 3-year survival probability of the NLA group at each quartile tended to be better than that of the RLA group, except for quartile 1. Table 5 shows the results of stepwise multivariate analyses in the Cox proportional hazard model, crude and stratified by PS. Among the 15 variables that were evaluated, two turned out to be statistically significantly associated with mortality. These were sex (hazard ratio (HR): 0.12, 95% CI: 0.02-0.69, p = 0.017) and the serum CEA level (HR: 2.39, 95% CI: 1.39-4.10, p = 0.002). There was no protective effect on mortality by RLA; the HR for the RLA group relative to the NLA group was 0.94 (95% CI: 0.32-2.82, p = 0.92) in multivariate analysis without considering the PS, and 0.95 (95% CI: 0.27-3.28, p = 0.93) in the propensity-based stratifying analysis.
Discussion
This study found no evidence that RLA contributes to a significantly better survival rate in lung cancer surgery for elderly patients. Thoracic surgeons should carefully consider two important points of view when determining the extent of a lymphadenectomy during a resection for NSCLC. One is, needless to say, whether it would contribute to a survival benefit, and the other is the accurate staging of lung cancer by examining mediastinal lymph node. In addition to these favourable effects of a lymphadenectomy, surgeons should give sufficient thought to the invasiveness of the procedure that might affect the morbidity rate. A number of retrospective and prospective studies have been conducted to assess the surgical benefit and detriment according to the lymph node dissection procedure. However, the results and conclusions of these studies were inconsistent as reported previously [9] [10] [11] [12] [16] [17] [18] [19] [20] .
These controversial results of previous studies have thus led investigators to explore the possibility of avoiding RLA. Okada et al. conducted a study to evaluate the possibility for early-stage lung cancer, and reported that selective mediastinal dissection for stage I NSCLC was as effective as an RLA [11] . Ishiguro et al. investigated the impact of lymph node dissection on OS, comparing RLA and selective lymphadenectomy (SD) based on lobe-specific lymph node metastases [21] . They concluded that those undergoing an SD did not have a significantly poor survival impact in comparison to RLA, and also advocated that an SD could contribute to reducing the invasiveness of the operation. They also reported the shorter operative time, lesser blood loss and shorter hospital stay in SD patients' group than in the RLA group. These findings might suggest the justification of avoidance of RLA.
Recent studies confirmed that surgical treatments in elderly patients with lung cancer should not be withheld Fig. 1 . Survival curves for patients with each procedure group of lymph node dissection. The crude 3-year survival probability was 81.3% (95% CI: 67.1-89.8) for the NLA group, which was marginally better than that of the RLA group (77.5% (95% CI: 63.3-86.8)). There was no significant difference in the overall survival between the two groups ( p = 0.26). Table 4 The 3-year survival probabilities after pulmonary resection stratified by PS quartile.
NLA RLA p-value 3-year survival (%) (95% CI) 3-year survival (%) (95% CI) PS, propensity score; NLA, non-radical lymphadenectomy; RLA, radical lymphadenectomy; CI, confidence interval. Table 5 Hazard ratios for covariates of survival after resection for lung cancer in the elderly. reported that the 5-year survival according to the type of lymph node dissection, with or without radical mediastinal lymph node dissection, was not significantly different for stage I NSCLC in octogenarians. They also reported that the postoperative pulmonary complication was more frequent in the patients with radical dissection, although the difference was not significantly different [22] . Meanwhile, Chida et al.
reported that a pulmonary resection with an RLA is associated with a higher rate of mortality and postoperative cardiac complications in octogenarians with lung cancer [12] . In this study, common complications of radical systematic mediastinal lymphadenectomy such as recurrent nerve palsy and chylothorax occurred in 4.2% in the RLA group, but did not occur in the NLA group. We also found a tendency of higher rate of postoperative complications, including atrial arrhythmia, prolonged air leakage and pneumonia, in the RLA group than in the NLA group. Although these results supported the justification of nonperformance of an RLA in the surgical treatment of elderly lung cancer patients, the possible bias in treatment selection could not be eliminated in the previous series. Therefore, the current study used a PS analysis to estimate the explanation for non-performance of RLA between two better-balanced procedure groups though designed retrospectively. This series showed no significant difference in the mortality between the two procedures of lymph node dissection, by both conventional and propensity-based stratified analyses. These findings suggested that the avoidance of radical lymphadenectomy could be justified in resections for elderly patients. Of course, definite evidence can be demonstrated only by randomised controlled trials; however, we believe that a retrospective study analysed carefully could supply an encouraging data for bringing in a new proper strategy in this era of ageing patients.
In conclusion, no survival benefit was observed for RLA combined with a pulmonary resection in this cohort. Although some reports recommend RLA for proper staging and better survival, a pulmonary resection without RLA could be an acceptable surgical treatment for elderly patients with NSCLC. Thoracic surgeons should therefore carefully select the proper, least invasive procedure of treatment, especially for elderly patients. Further investigations are warranted to determine the minimally required and optimal surgical treatment for elderly lung cancer patients.
pointed out by the authors, whose manuscript I just received in time for this meeting, systematic lymph node dissection may not only be related to improved staging but also to better survival. The first point has been clearly shown, the second, not yet, although a randomized trial performed in China demonstrated a survival advantage for patients undergoing lymph node dissection. The ACOSOG, American College of Surgeons Oncology Group, Trial Z0030 performed in the U.S., randomising between sampling and formal lymphadenectomy, showed a significant difference in chest drain output but no difference in mortality or hospital stay, but the final survival results are still awaited. I have several questions for the authors, and you can probably address them one by one.
First of all, this is a retrospective, nonrandomised trial which was most probably designed as a non-inferiority trial. Was there any sample size calculated or power for this study?
Dr Okasaka: You asked about the study design? Dr Van Schil: Yes, and the sample size to show a difference. How many patients did you really need to observe a difference?
Dr Okasaka: For example, if this was a prospective, randomised, controlled study, we would need to show the sample size to show the significance, but with this propensity score calculation, we have no sample size calculation to show the significance of the difference.
Dr Van Schil: But did you have enough patients to potentially show a difference?
Dr Okasaka: I think this is a little bit of a smaller sample size, so I would like to do more patients and further analysis.
Dr Van Schil: What is not clear from the manuscript is how many surgeons were involved and how did they decide during the operation which procedure to perform, sampling or lymphadenectomy?
Dr Okasaka: The surgeon is a very important factor in deciding the procedure during the operation. In this study, there were 8 or 9 surgeons who participated in these operations, but we decided the procedure in the weekly team meeting; so, for example, surgeon 1, 2, or 3 did not affect our results. Dr Okasaka: When we calculated the propensity score, we only needed the clinical stage, so in my manuscript I didn't talk about pathological stage.
Dr Van Schil: I noticed that your groups were very heterogeneous. For example, segmentectomies were performed in only 1.4% in the radical group versus 29% in the non-radical group, and the 4-year survival in your fourth quartile was 80% in the non-radical group versus only 41% in the radical group. I'm not a statistician, but does propensity score analysis really compensate for that, or could it also be due to selection bias?
Dr Okasaka: Sorry, I didn't understand. Dr Van Schil: When you look at the data, your groups were very heterogeneous. Does the propensity score analysis you performed really compensate for the large differences in heterogeneity?
Dr Okasaka: I calculated the statistical data, and the appearance of the two groups is correct in this calculation.
